Gross profit · 2016–2023
Acadia Pharmaceuticals gross profit
$685M+35.1% · FY2023
Acadia Pharmaceuticals (ACAD) reported $685M in gross profit for fiscal 2023, +35.1% year on year.
| Fiscal year | Gross profit | Change | Filing |
|---|---|---|---|
| FY20232023-12-31 | $685M | +35.1% | Open → |
| FY20222022-12-31 | $507M | +7.1% | Open → |
| FY20212021-12-31 | $473M | +9.7% | Open → |
| FY20202020-12-31 | $432M | +31.7% | Open → |
| FY20192019-12-31 | $328M | +55.0% | Open → |
| FY20182018-12-31 | $211M | +82.5% | Open → |
| FY20172017-12-31 | $116M | +712.7% | Open → |
| FY20162016-12-31 | $14.3M | — | Open → |
Gross profit — Gross profit is revenue minus the direct cost of goods and services sold. Not every company reports it; those that do not are absent from this ranking.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2016–2023 compound annual growth +73.9%
Gross profit at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Acadia Pharmaceuticals gross profit |url=https://companiesranked.com/en/company/acadia-pharmaceuticals/gross-profit |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Acadia Pharmaceuticals gross profit. CompaniesRanked. https://companiesranked.com/en/company/acadia-pharmaceuticals/gross-profitBibTeX
@misc{companiesranked-en-company-acadia-pharmaceuticals-gross-profit-2026,
author = {{CompaniesRanked}},
title = {{Acadia Pharmaceuticals gross profit}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/acadia-pharmaceuticals/gross-profit}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.